Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Amazon CFO Says Co. Will Continue To Look At Hiring Freeze As Time Progresses

-Reuters
byMichael Horton
February 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

-Reuters

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Mirati Therapeutics Announced Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer; Said Adagrasib Demonstrates Promising Clinical Efficacy and Favorable Tolerability as a Monotherapy and in Combination With Cetuxim…

By Charles Gross
September 7, 6:54 PM
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced results from KRYSTAL-1, a multicohort Phase 1/2 study, evaluating adagrasib with or without cetuximab in patients with advanced CRC harboring a KRASG12C mutation.

MRTX